Lobbying client
URL PHARMACEUTICALS
drug pricing issues
Filings
6
Filed by
1
Reported in-house
—
Reported by firms
$130,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2011 to 2012
Filings
2 filings for 2012, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Termination Amendment 1st Quarter 2012
|
IKON PUBLIC AFFAIRS | $40,000 reported |
|
1st Quarter - Reportreplaced 1st Quarter 2012
|
IKON PUBLIC AFFAIRS | $40,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| IKON PUBLIC AFFAIRS | 4 | $130,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Pharmacy | PHA | 5 |
| Medicare/Medicaid | MMM | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.